Lv31
384 积分 2022-06-28 加入
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
4天前
已完结
Why Do Men Reject Adjuvant Radiotherapy following Radical Prostatectomy? A Systematic Survey
5天前
已完结
Adherence to Hormonal Therapies in Prostate Cancer
5天前
已完结
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy—A Multicenter Study
5天前
已完结
Risk prediction models for biochemical recurrence of Chinese prostate cancer patients after radical prostatectomy based on magnetic resonance imaging examination: a systematic review
5天前
已完结
Long-term unmet supportive care needs of prostate cancer survivors: 15-year follow-up from the NSW Prostate Cancer Care and Outcomes Study
7天前
已完结
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
12天前
已完结
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
12天前
已完结
Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study
12天前
已完结
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis
20天前
已完结
皖公网安备34019202002308
